Added to YB: 2026-08-21
Pitch date: 2026-08-19
BSX [bullish]
Boston Scientific Corporation
-4.4%
current return
Author Info
Aurelion Research is a research analyst with a passion for markets, specializing in high‑conviction ideas across shipping, offshore drilling, and thematic equity research. Sign up for the newsletter.
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$75.4B
Pitch Price
$51.64
Price Target
67.00 (+29%)
Dividend
N/A
EV/EBITDA
15.36
P/E
21.07
EV/Sales
4.18
Sector
Health Care Equipment and Supplies
Category
value
Boston Scientific (BSX): New Position
BSX (new position): High-quality medtech at 12x earnings vs 20x historical avg after Farapulse (competition) & Watchman (weak demand) growth engines stalled (25% of rev). Other 75% grows 6-7%; 2027 2-4% framework seen as floor. CEO bought $9M, $2B buyback, new launches 2027-28. PT $67 YE2026.
Read full article (14 min)